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Background: Early detection of individuals at risk for converting to Alzheimer’s disease 
(AD) can potentially lead to more efficient treatment and better disease management. A 
well-known approach has aimed at identifying individuals at the prodromal stage of 
dementia; namely, Mild Cognitive Impairment (MCI). Past studies showed that MCI 
subjects often have accelerated rates of conversion to AD, or to other types of dementia 
compared to healthy controls (HCs). However, with more investigations of the MCI 
population, it became evident that a high level of heterogeneity exists within this group: 
many remain clinically stable even after 10 years. MCI subtypes defined by the 
conventional classification criteria showed inconsistent results for determining an 
individual's risk of AD. As another approach, neuroimaging techniques such as magnetic 
resonance imaging (MRI) are able to successfully identify neurological changes during 
early AD. MRI markers including morphological, connectional and abnormal signal 
patterns in the brain have been shown to have good sensitivity for classifying AD. Based 
on these findings, recent studies started implementing these imaging markers to create 
computer-aided classification models for predicting the risk of conversion to AD. Most of 
these studies enrolled MCI subjects who remained stable or converted to AD within 3 
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years, and generated computer-aided classification models to predict conversion using 
various imaging markers and clinical data. To our knowledge, no classification models 
proposed achieved an accuracy of higher than 80% for predicting MCI-AD conversion 
earlier than 3 years with only using structural MRI features. In this paper, we tested the 
prediction range beyond 3 years, and suggested new candidate imaging measures for 
earlier prediction. 
Methods: The subjects included in the current study are n=51 MCI non-converter, n=157 
MCI converter (115 fast converters and 42 slow converters) and n=38 AD, selected from 
the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database. Using subjects' 
baseline T1-weighted MRI scans, we combined conventional morphometric measures 
(e.g. cortical thickness, surface area, volume, etc.) with novel intensity measures to 
differentiate MCI converters from non-converters. We additionally applied a machine 
learning approach to classify MCI subgroups by combining features in multiple 
measurement domains. 
Results: Based on group comparison using independent t-test, we found that while MCI 
fast converters (conversion within 0-2 years) were highly distinct from MCI non-
converters across many cortical and subcortical regions, MCI slow converters 
(conversion within 3-5 years) demonstrated more focal differences from MCI non-
converters mainly in the temporal regions and hippocampal subfields. We identified 
unique imaging features associated with each converter group and had improved 
classification performance on both MCI converter groups by adding those markers. The 
best performing classifiers combined conventional imaging features, novel intensity 
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features and neuropsychological features. For our best performing classification models, 
we were able to classify MCI fast converters (0-2 years) from non-converter with an 
average accuracy of 86.1%, sensitivity of 85.5%, and specificity of 89.8%, and to classify 
MCI slow converters (3-5 years) from non-converters with an accuracy of 80.5%, 
sensitivity of 75.7%, and specificity of 82.3%.  
Conclusion: Our results demonstrated the potential of the suggested approach for 
predicting the conversion from MCI to AD at an even earlier time point (3-5 years) 
before the onset of AD. The combination of standard morphometric features and 
proposed novel intensity features improved the sensitivity of using T1-weighted MRI for 
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Mild cognitive impairment (MCI) is a transitional phase between normal 
cognitive aging and Alzheimer’s disease (AD) in which individuals demonstrate 
objective cognitive impairment but have relatively intact abilities. An early study showed 
that MCI subjects have accelerated rates of conversion to AD, at 12% per year, compared 
to the annual rate of 1-2% among healthy controls (HC) (Petersen, 2004). However, 
further investigations of the MCI population revealed a high level of heterogeneity: while 
a portion of individuals rapidly converted to AD following an MCI diagnosis, others 
remained clinically stable even after 10 years (Mitchell & Shiri-Feshki, 2009). To 
account for the heterogeneity, the conventional classification criteria of MCI subtypes 
further divided MCI subjects into subgroups based on clinical evaluations, which 
includes amnestic MCI (aMCI), non-amnestic MCI (naMCI), single- or multiple-domain 
MCI (Peterson, 2004). The prognostic value of this criteria was later challenged by 
multiple studies showing that all 4 MCI subtypes follow a similar disease progression 
trajectory (Busse et al., 2006, Fischer et al., 2007). These subtypes of MCI were not 
successful in predicting early stages of dementia since both aMCI and naMCI subjects 
converted to AD at a similar rate. A 3-year longitudinal study showed that the 
progression rate to dementia is similar for naMCI (22.2%) and aMCI (34.5%) (Duara et 
al., 2011). Concerns then arise regarding the sensitivity of such classification systems and 




Independent of clinically-defined MCI subtypes, later studies defined potential 
biomarkers that are associated with the MCI-AD conversion, such as cerebrospinal fluid 
(CSF) markers, vascular risk factors (e.g. atrial fibrillation) (Ravaglia et al., 2006), 
genetic profiles (e.g. ApoE4 carrier status), and neuroimaging markers (e.g. hippocampal 
atrophy). In particular, T1-weighted structural MRI scans have been routinely used for 
assessing many neurological diseases, they are more easily accessible than PET or 
diffusional MRI, and are less invasive than collecting CSF samples. An early structural 
MRI study showed that MCI subjects who later converted to AD demonstrated a similar 
pattern of neurodegeneration as AD group (greater hippocampal atrophy and entorhinal 
cortex thinning than stable MCI subjects), as early as one year before AD diagnosis 
(Risacher et al., 2009). Similarly, a 3-year longitudinal study showed that MCI converters 
demonstrated a more rapid and widespread GM atrophy than those who remained 
clinically stable (Whitwell et al., 2008). A more recent paper showed that the 
combination of baseline brain volume and annual atrophy rate were predictive of the time 
to conversion from MCI to AD (Tabatabaei-Jafari et al., 2019). The studies using 
conventional GM morphometric measures provided the earliest evidence on describing 
the heterogeneity of the MCI population, and provided valuable insights to studying the 
MCI-AD conversion. However, it is worth noting that 1) these studies often requires data 
at multiple time points for estimating the rate of MCI-AD conversion, 2) their approach 
often infers the risk of conversion solely based on previously well-defined AD pathology 
(e.g. hippocampal atrophy), and may overlook other subtle differences within the early 
MCI population.  
 
3 
Hippocampal atrophy is a hallmark of AD, but its role in MCI-AD conversion is 
not fully understood. More recently, hippocampal subfield volumes have gained 
increasing popularity among studies of MCI, as evidence suggest that this measure may 
have better sensitivity for detecting pathology at an earlier stage of disease compared to 
the whole hippocampal measures. As reviewed by Flores et al. (2015), while the AD 
subjects showed significant atrophy in almost all subfields, MCI subjects showed focal 
atrophy of cornu ammonis 1 (CA1) and subiculum. This pattern was more pronounced in 
progressive MCI who converted to AD within 2 years compared to those who remained 
stable. Longitudinal studies showed that as individuals progress to AD, the atrophy is 
then spread to the rest of the hippocampus.  
Disruption of the white matter (WM) intensity profile has been shown to occur in 
the early stage of MCI. A study that measured WM signal abnormality showed that the 
rate at which WM damage occurs differs between MCI non-converter and converters, and 
can be detected at least 18 months prior to AD onset (Lindemer et al., 2015). Several 
other studies showed that WM hyperintensity volume (WMHV) is greater in MCI 
converters than non-converters. For example, subjects with normal entorhinal cortex 
volume but high WMHV demonstrated more aggressive cognitive decline and higher risk 
of conversion to AD than their counterparts with low WMHV (Tosto et al., 2014). 
Similarly, Dadar et al. (2019) showed that the risk of AD conversion is associated with 
increased intensity of T2-weighted periventricular and juxtacortical WMHs. The rate of 
conversion (measured by greater cognitive decline over a fixed time interval) was also 
associated with both WMH and T1-weighted hypointensity (Dadar et al., 2019). These 
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findings suggest that distinct neurobiological changes of WM between MCI converters 
and non-converters can be detected long before the actual diagnosis of AD.  
In addition to individual regional measures, brain connectomes provide means for 
generating a comprehensive map of all brain structures and their connections to each 
other (Evans, 2013). This analytical tool can potentially improve our understanding and 
treatment of several disorders by shedding light on how each region of the brain is 
differentially integrated in neurological diseases. For example, different sub-networks in 
the brain are selectively targeted in different dementia subtypes (Seeley et al., 2008; Zhou 
et al., 2010). Compared to the healthy aging cohort, AD subjects demonstrated a greater 
decline of structural connectivity of default mode network, which was also associated 
with cognitive performance and ApoE4 status (Spreng & Turner, 2013). Another study 
corroborated these findings by showing that AD patients had significantly reduced 
morphological network connections when compared to normal control subjects (Kim et 
al., 2016). These findings suggest that structural connectivity measures may provide 
additional key features for better characterization of MCI heterogeneity.  
In the last few years, different machine learning (ML) approaches have been 
applied to the single subject level diagnosis and prognosis of AD from MRI studies, with 
good performance even as early as 3 years before the onset of AD, when pathological 
signs are not yet evident by visual inspection (reviewed in Moradi et al., 2015). By using 
features only from structural MRI scans, previous studies achieved an accuracy ranging 
from 70-76% for the classification of MCI converters vs. non-converters. The addition of 
clinical data (i.e. subject demographics, APOE4 genotype, and neuropsychological 
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assessments) to the classifier improved the accuracy to 80-84% (Moradi et al., 2015, 
Tong et al., 2017). The addition of other imaging modalities (i.e. PET and resting-state 
fMRI) to conventional structural MRI also slightly improve the accuracy of the classifiers 
(Hojjati et al., 2018, Gupta et al., 2019). A most recent study using the deep learning 
method achieved 86% accuracy, 87.5% sensitivity, 85% specificity for classifying MCI 
converter (0-3 years) and non-converters, by using both baseline T1-weighted MRI 
features and clinical data (Spasov et al., 2019). However, studies on predicting MCI-AD 
conversion at earlier time points did not show a matching level of performances. For 
example, a study combining cerebrospinal fluid (CSF) markers, PET imaging features, 
and MRI features showed an accuracy of 72% for classifying MCI converters (0-48 
months) and non-converters (Shaffer et al., 2013). Another study using only MRI 
volumetric measures achieved an accuracy of 77.0% (sensitivity = 59.6, specificity = 86.1) 
for classifying MCI converters (0-48months) and non-converters (Ezzati et al., 2019). 
The combination of neuroimaging and ML techniques may allow effective identification 
of complex imaging feature(s), which would likely be overlooked by clinicians. 
However, predicting conversion to AD at an early very stage of MCI (e.g. 5 years before 
conversion) still required further investigations.  
Based on the findings presented above, the current study will combine 
conventional morphometric measures with our novel intensity measures, network 
measures, and hippocampal subfield measures extracted from T1-weighted MRI to 
demonstrate different subgroups within the MCI cohort. We aimed to 1) demonstrate 
neurological differences between MCI subjects who converted to AD within 0-2 years 
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(“fast converters”),  who converted to AD within 3-5 years (“slow converters”), and those 
who remain stable (“non-converters”) through pairwise group-level statistical 
comparisons of T1-weighted MRI and neuropsychological data to define unique features 
associated with each group, and 2) develop a primarily neuroimaging-based, 
computational model for automated classification using proposed T1-weighted MRI 
markers alone, or combined with other clinical measures. We hypothesized that there are 
both overlapping and unique neuroimaging features between MCI fast converters, slow 
converters and non-converters, and using these features, we can predict the risk and the 





 Data were obtained from the Alzheimer’s Disease Neuroimaging Initiative 
(ADNI) database (adni.loni. usc.edu). ADNI-1 was the first phase of ADNI launched in 
2004 by the National Institute on Aging (NIA), and several pharmaceutical companies 
and foundations. The primary goal of ADNI is to test whether neuroimaging, other 
biological markers, and clinical and neuropsychological assessment can be used for early 
and accurate detection and tracking of AD. ADNI-1 is a 6-year longitudinal study that 
consisted of 400 subjects diagnosed with MCI, 200 subjects with early AD, and 200 
elderly healthy control subjects, within the ages of 55 to 90 years. The study was 
approved by the institutional review boards of all participating institutions. Informed 




For the present work, a total of 208 subjects were retrieved from the ADNI-1 database, 
consisting of 51 subjects with a consistent diagnosis of MCI (MCI non-converters) for at 
least 5 years from baseline, 157 subjects with a baseline diagnosis of MCI who later 
converted to AD during 5 years of follow-up (MCI converters). Among 157 MCI 
converters, we further identified 2 subgroups based on their time of conversion to AD. 
The MCI fast converters (MCIc_fast) consisted of n=115 subjects who converted to 
AD≤2 years from baseline, and MCI slow converters (MCIc_slow) that consisted of n=42 
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subjects whose conversion took between 3-5 years from baseline. MCI subjects who 
reverted back to the cognitively normal (CN) state, or whose conversion occurred at >5 
years from baseline were excluded from our analysis. The demographic characteristics of 
each subject group considered in this study are shown in Table 1.   
Table 1. Characteristics of the baseline population 
 Participants 
 MCIc_fast MCIc_slow MCInc All 
No. of cases 115 42 51 208 
Age, years     
Range 55-88 55-85 58-88 55-88 
Mean (SD) 74.3 (7.3) 74.0 (7.1) 73.9 (7.9) 74.2 (7.4) 
Sex, n (%)     
Male 73 (63) 28 (67) 35 (69) 136 (65) 
Female 42 (37) 14 (33) 16 (31) 72 (35) 
Education, years     
Mean (SD) 15.7 (2.9) 16.2 (2.9) 15.3 (3.2) 15.7 (2.9) 
ApoE4 carrier status, n (%)     
0 allele 38 (33) 16 (38) 30 (59) 84 (40) 
1 allele 57 (50) 20 (48) 17 (33) 94 (45) 
2 alleles 20 (17) 6 (14) 4 (8) 30 (14) 
Time to conversion, months     
Range 0-24 36-60   
Mean (SD) 15.2 (7.1) 43.4 (8.8)   
MMSE, mean (SD) 26.5 (1.7) 26.8 (1.5) 27.7 (1.7) 26.9 (1.7) 
AD = Alzheimer’s Disease, MCIc_fast = fast MCI converter, MCIc_slow = slow MCI converter, 




ADNI’s MCI diagnoses were based on the following: (1) subjective memory 
concern reported by the participant, study partner, or clinician; (2) abnormal memory 
function documented by scoring within education-adjusted ranges on delayed free recall 
of Story A from the WMS-R Logical Memory II subtest; (3) Mini-Mental State 
Examination (MMSE) score between 24 and 30; (4) global Clinical Dementia Rating 
(CDR) score of 0.5, with a Memory Box score of at least 0.5; and (5) general cognition 
and functional performance sufficiently preserved such that a diagnosis of AD could not 
be made.  
 
Neuropsychological data 
Baseline neuropsychological data were obtained for each subject from the ADNI 
database. Neuropsychological data included both scores and subscores of several 
neuropsychological tests, including the Clinical Dementia Ratio Sum of Boxes (CDRSB), 
Alzheimer Disease Assessments Scale (ADAS), Mini-Mental State Examination 
(MMSE),  Rey Auditory Verbal Learning Test (AVLT), delayed recall total 
(LDELTOTAL), Digit Symbol Substitution Score (DIGITSCOR), Trail Making Test 
(TRABSCOR), Activities of Daily Living (FAQ). The full list of neuropsychological 





Table 2. Baseline neuropsychological testing scores (data presented as group median) 
 Participants 
Test MCIc_fast MCIc_slow MCInc 
CDRSB 2 1.5 1.5 
ADAS11 13 11.835 8.67 
ADAS13 21.33 19.33 15 
ADASQ4 8 7 4 
MMSE 26 27 28 
RAVLT_immediate 26 30.5 34 
RAVLT_learning 3 3 4 
RAVLT_forgetting 5 5 5 
RAVLT_perc_forgetting 100 75 55.5556 
LDELTOTAL 2 4 4 
DIGITSCOR 33 38.5 41 
TRABSCOR 124 100 94 
FAQ 5 3 1 
 
Image Acquisition and processing 
We downloaded baseline MR images from each subject in 3D NIfTI 
(Neuroimaging Informatics Technology Initiative) format. According to the ADNI MRI 
acquisition protocol (Jack et al., 2008), examinations were performed at 1.5 Tesla using a 
T1-weighted 3D MP-RAGE sequence. The MR images were acquired with following 
image parameters: sagittal plane, repetition time/echo time/inversion time 2400/3/1000 
ms, flip angle 8, 24 cm field-of-view, 192 × 192 in-plane matrix, and 1.2-mm slice 
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thickness. Images which had undergone specific ADNI preprocessing correction steps to 
standardize images from different sites and platforms were obtained for this study: (1) 
Grad wrap: a specific correction of image geometry distortion due to nonlinearity, (2) B1 
nonuniformity: B1 calibration to correct the image intensity nonuniformity that results 
when RF transmission is performed with a more uniform body coil while reception is per- 
formed with a less-uniform head coil, (3) N3 correction: a histogram peak sharpening 
algorithm applied after grad wrap and B1 correction (refer to ADNI website MRI 
protocol at adni.loni. usc.edu). 
Processing procedure was then performed on the downloaded images using 
Freesurfer v6.0 (http:// surfer.nmr.mgh.harvard.edu/), this procedure consisting in: (1) 
image re-orientation; (2) cropping; (3) skull-stripping; (4) image normalization to the 
MNI standard space by means of co-registration to the MNI template (MNI152 T1 1-mm 
brain) (Grabner et al., 2006). MR images underwent automated segmentation into 62 
cortical regions of interests (ROIs) based on Desikan-Killiany atlas, 32 subcortical ROIs, 
and 44 hippocampal subfield ROIs using Freesurfer in-built atlas. (Desikan et al., 2006; 
Fischl and Dale, 2000; Iglesias et al., 2015).  
 
Imaging Measurements 
From the Freesurfer outputs, we applied different statistical approaches to extract 
12 imaging features from each subject, including cortical thickness, cortical volume, 
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grey-white matter ratio, WM intensity, GM intensity, subcortical volume, hippocampal 
subfield volume, GWMR skewness, WM skewness, GM skewness, and GWMR network 
(Table 3).   
Table 3 Summary of imaging measures 




Cortical Thickness Through Freesurfer pipeline with in-built 
atlas, as described in Desikan et al., 2006; 












Salat et al., 2009 





GWMR skewness Inspired by Evans 2013 and Kim et al., 
2016 






ROI-level morphometric measures:  
ROI-level intensity measure: For each ROI, WM signal intensity was measured at 
a projection fraction of 1.0 below the cortical surface. GM signal intensity was measured 
at a projection fraction of 0.3 below the cortical surface. GWMR was calculated for each 
ROI using both WM and GM intensity values (Jefferson et al., 2016) (Figure 1).  
In addition to ROI-level intensity measures, we developed novel markers such as 
skewness and connectivity network to detect more subtle differences in local intensity 
profiles:  
• Skewness analysis: Each subject’s cortical surface model was first resampled to 
over 10,000 vertices per hemisphere and then these vertices were grouped 
according to ROIs. For each ROI, the skewness of the intensity profiles sampled 
from T1 weighted image intensity measures (i.e. GWMR, WM intensity, GM 
intensity) extracted from all vertices were calculated. We used the absolute value 
of skewness to indicate whether the distribution is more skewed or closer to 
normal distribution.   
• Network analysis: We constructed individualized structural covariance networks 
of each subject to demonstrate connectivity information between each pair of 
ROIs. Using the same vertex-based approach, vertex-wise GWMR values of each 
ROI were described by distribution parameters (i.e. mean and standard deviation) 
and were used as the basis for defining connectivity. With the mean and standard 
deviation from each ROI, z-scores are calculated to represent how much the 
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distribution of one ROI deviates from the other ROI. Calculations: As described 
previously by Kim et al. (2016), we extracted the mean (Mi) and standard 
deviation (Si) of the morphometric measure (i.e. GWMR) in the i-th ROI, and 
similarly, Mj and Sj for another ROI j. Using these values, we calculated z-scores 
as Z (i, j) = (Mi − Mj/Sj), which signifies how much the GWMR of the i-th ROI 
deviates from that of the j-th ROI on average. Similarly, Z(j, i) can be computed 
using the mean and standard deviation of the i-th ROI. Since we are measuring 
the magnitude of deviation between a pair of ROIs without considering any 
directionality, we defined a symmetric connectivity matrix C(i, j) between nodes i 
and j as the mean of Z(i, j) and Z(j, i), shown as C(i, j) = ((|Z (i, j)| + |Z (j, i)|))/2. 
Here, we used magnitude values of the average z-scores, since the structural 
connectivity between two ROIs in our network definition measures the extent of 
similarity in GWMR distribution between ROIs. This resulted in a total of 3844 
connections for each subject. The significant connections are defined based on 
ANOVA tests between 4 groups with p<0.05, and non-significant connections are 
removed from further analysis. Then for each subject, the average value of the 





Figure 1 Extraction of novel intensity measures skewness and network. This graph 
provides an overview to the extraction method for our proposed MRI markers, skewness 
and network. After image preprocessing, we extracted signal intensity value at each 
vertex and grouped vertices based on the ROIs. With these values, we calculated the 
skewness of intensity values for each vertex (Intensity Skewness), and we also 
constructed individual connectivity networks (Intensity Network). 
 
Statistical analyses 
Data was analyzed using an in-house developed MATLAB script (MATLAB, The 
MathWorks). For analysis of neuropsychological testing scores, we report medians and 
use nonparametric methods due to skewness in these variables. In specific, Kruskal-
Wallis tests were used to compare fast and slow MCI converters, MCI non-converters, on 
age and years of education. A chi-squared test was used to compare groups on gender and 
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the proportion of apolipoprotein 4 (APOE4) carriers. Two-sided two-sample Wilcoxon 
rank-sum tests were used to compare the groups on the cognitive test scores, including 
the MMSE, CDR sum of boxes (CDR-SOB), and RAVLT. For imaging measures, we 
conducted pairwise comparison using a 2-sample T-test to detect differences in each of 
12 imaging features between a pair of MCI converters (fast and slow), and MCI non-
converters. Prior to statistical analysis, the effect of age and gender were estimated and 
removed using a linear regression model, outliers (defined as ±3SD) were also removed 
from the data. Significant group differences were thresholded at p <0.05 after false 
discovery rate (FDR) correction (Noble, 2009).  
 
Machine learning classifier 
To build a computer-aided classifier for predicting the risk of conversion from 
MCI to AD (i.e., MCI_c fast vs. MCInc, and MCIc_slow vs MCInc), we employ an in-
house pipeline, canonical correlation forest (CCF), which is a modified version of the 
random decision forest classification (RDF) that combines with rotating feature space 
method to yield consistent and fast boundary searching results (Rainforth & Wood, 
2009). RDF performs iterative partitioning of the multivariate feature space to identify 




 The features that were used to train the classifier were selected based on results of 
group comparisons of imaging and neuropsychological measures described in the 
previous section. In specific, subsets of features that were significantly different between 
the two groups were selected for building the classifier. To optimize the performance of 
the classifier and to reduce the effects of model underfitting and overfitting, we trained 
and compared several classifiers that used feature sets selected based on different p-value 
thresholds. For MCIc_fast vs. MCInc classification, we tested and compared models 
using different feature sets that are thresholded at a range of p-values from FDR-
corrected p<0.05 to uncorrected p<0.000005, respectively. For MCIc_slow vs. MCInc 
classification, we tested and compared several models using features selected at p-values 
ranging from FDR-corrected p<0.05 to uncorrected p<0.05. In addition, age- and gender-
related confounds were removed from the raw data before training the model. This step is 
achieved by estimating the effect and age and gender on imaging measures using a linear 
regression model that is similar to a method applied in an early study (Moradi et al., 
2015).  
To assess the performance of the classifiers, CCF uses cross-validation that 
randomly holds out n numbers of subjects as the testing group, and uses the rest of the 
subjects as the training group. The performance of the classifier was then evaluated based 
on average accuracy, sensitivity and specificity using the test subset, over 100 iterations 
of cross-validation in order to minimize the effect of the random variation. The best 




Alternative classification approach: Cluster analysis and other classification 
algorithms 
As an alternative approach for classifying MCI subgroups, we hid subjects’ true 
labels and applied the expectation maximization algorithm (EMA) to identify clusters 
within the entire sample (Do & Batzoglou, 2008). After defining the number of features 
to select from each type of measure (e.g. thickness, volume, etc.) from the dataset, the 
algorithm would randomly select a subset of features during each iteration of 
classification to define clusters and assign a label to each subject. To deal with the large 
number of features that we generated, we additionally applied the principal component 
analysis (PCA) method to reduce dimensionality of the input data (Lever, 2017).  
To evaluate the performance of the classification, the model-generated label is 
then being compared with the true label. Without prior knowledge of true labels to train 
the model, we expect that only a portion of iterations will show good performance. Here 
we report the accuracy, sensitivity, specificity, and the features that were selected in the 










1. Group comparison 
We first conducted pairwise comparisons: (1) MCIc_fast vs. MCInc, and (2) 
MCIc_slow vs MCInc on 12 MRI measures using independent t-tests, significant results 
are reported if FDR-corrected p<0.05 (see feature highlights in Fig 2). 
 
Figure 2. Summary of independent t-test results for comparing imaging 
neuropsychological measures. The significant features (FDR-corrected p<0.05) are 
plotted, where rows represent each imaging/neuropsychological measure and columns are 
ROIs. The numbers on the x-axis represent ROI which can be found in the ROI list. Light 
blue represents negative t-value, while dark blue represents positive t-value. The symbols 
within each box represent if the significant feature is bilateral or unilateral: “*” bilateral, 
“L” left hemisphere, “R” right hemisphere. MTL: medial temporal lobe. 
Neuropsychological tests with subscores are indicated by the labels on the squares. 
 
Table 4 ROI list 
Label  Cortical ROIs Subcortical + hippocampal subfield ROIs 
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1 Superiorfrontal Lateral-Ventricle 
2 Rostralmiddlefrontal Inf-Lat-Vent 
3 Caudalmiddlefrontal Cerebellum-White-Matter 
4 Parsopercularis Cerebellum-Cortex 
5 Parsorbitalis Thalamus-Proper 
6 Parstriangularis Caudate 
7 Medialorbitofrontal Putamen 
8 Lateralorbitofrontal Pallidum 
9 Precentral Hippocampus 
10 Rostralanteriorcingulate Amygdala 
11 Caudalanteriorcingulate Accumbens-area 
12 Posteriorcingulate VentralDC 
13 Isthmuscingulate vessel 
14 Postcentral choroid-plexus 
15 Paracentral Hippocampal_tail 
16 Superiorparietal subiculum-body 
17 Inferiorparietal CA1-body 
18 Precuneus subiculum-head 
19 Supramarginal hippocampal-fissure 
20 Superiortemporal presubiculum-head 
21 Middletemporal CA1-head 
22 Inferiortemporal presubiculum-body 
23 Transversetemporal parasubiculum 
24 Entorhinal molecular_layer_HP-head 
25 Fusiform molecular_layer_HP-body 
26 Parahippocampal GC-ML-DG-head 
27 Insula CA3-body 
28 Lingual GC-ML-DG-body 
29 Lateraloccipital CA4-head 
30 Pericalcarine CA4-body 
31 Cuneus fimbria 
32  CA3-head 
33  HATA 
34  Whole_hippocampal_body 
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35  Whole_hippocampal_head 
36  Whole_hippocampus 
 
1.1 ROI-level morphometric measures 
Thickness: Between MCI fast converters and MCInc, significant differences were found 
in 39 of 62 ROIs (FDR corrected p<0.05), with MCI fast converters having lower value 
in all 39 regions. The most significant regions (p<0.0005) include the bilateral entorhinal 
cortex, bilateral fusiform, bilateral inferior parietal lobe,  bilateral inferior temporal 
gyrus, bilateral middle temporal, bilateral precuneus, bilateral superior temporal, left 
rostral middle frontal, right lateral occipital, and right supramarginal. Between MCI slow 
converters and MCInc, significant differences were found in 1 of 62 ROIs (FDR 
corrected p<0.05). In specific, MCI slow converters showed lower thickness of the right 
entorhinal cortex compared to MCI non-converters (FDR-corrected p=0.04, t=-3.58).  
Surface area: Between MCI fast converters and MCInc, significant differences were 
found in 6 of 62 ROIs (FDR corrected p<0.05), with MCI fast converters having lower 
value in all 6 regions, include the bilateral inferior parietal cortex, bilateral inferior 
temporal, and bilateral middle temporal cortices. No significant differences were found 
between MCI slow converters and non-converters.  
Volume of cortical ROIs:  Between MCI fast converters and MCInc, significant 
differences were found in 27 of 62 ROIs (FDR corrected p<0.05), with MCI fast 
converters having lower value in all 27 regions. The most significant regions (p<0.0005) 
include the bilateral entorhinal cortex, bilateral inferior parietal lobe,  bilateral inferior 
temporal gyrus, bilateral middle temporal, left supramarginal, right superior temporal. 
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Between MCI slow converters and MCInc, significant differences were found in 1 of 62 
ROIs (FDR corrected p<0.05). In specific, MCI slow converters showed lower volume of 
the left supramarginal compared to MCI non-converters (FDR-corrected p=0.02, t=-
3.77).  
Volume of subcortical ROIs: Between MCI fast converters and MCInc, significant 
differences were found in 8 of 32 ROIs (FDR corrected p<0.05). Similar to AD subjects, 
MCI fast converters showed smaller bilateral hippocampus and amygdala, larger inferior 
lateral ventricles. In addition, MCI fast converters had smaller accumbens volumes 
bilaterally compared to MCI non-converters.  Between MCI slow converters and MCInc, 
significant differences were found in 5 of 62 ROIs (FDR corrected p<0.05). In specific, 
MCI slow converters showed lower volume of the bilateral hippocampus and amygdala, 
and smaller right accumbens.  
Volume of hippocampal subfield ROIs: Between MCI fast converters and MCInc, 
significant differences were found in 39 of 42 ROIs (FDR corrected p<0.05), with MCI 
fast converters having lower value in all 39 regions. The most significant regions (FDR-
corrected p<0.000005) include all regions listed for AD, as well as additional structures 
which are the bilateral presubiculum body, bilateral CA3 body, left GC-ML-DG head, 
left CA4 head, left CA4 body, and left HATA. Between MCI slow converters and 
MCInc, significant differences were found in 28 of 42 ROIs (FDR corrected p<0.05), 
with MCI slow converters having lower value in all 28 regions. The most significant 
regions (FDR-corrected p<0.005) include the bilateral hippocampal tail, bilateral 
subiculum head, bilateral CA1 head, bilateral molecular layer HP head, bilateral 
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hippocampal head, left subiculum body, left presubiculum head, left molecular layer HP 
body, left hippocampal body. 
 
1.2 ROI-level intensity measures 
GWMR: Between MCI fast converters and MCInc, significant differences were found in 
22 of 62 ROIs (FDR corrected p<0.05), with MCI fast converters having lower GWMR 
in all 22 regions. The most significant region is the left entorhinal cortex (p<0.001, t=-
4.56). Between MCI slow converters and MCInc, no significant differences were found 
after FDR correction.  
WM intensity: Between MCI fast converters and MCInc, significant differences were 
found in 3 of 62 ROIs (FDR corrected p<0.05). In specific, MCI fast converters have 
lower value in left fusiform (p=0.03, t=-3.33), left inferior temporal (p=0.03, t=-3.47), 
and right parahippocampal gyrus (p=0.04, t=-3.19). Between MCI slow converters and 
MCInc, significant differences were found in 2 of 62 ROIs (FDR corrected p<0.05). In 
specific, MCI slow converters showed lower WM intensity in the left fusiform (p=0.04, 
t=-3.39), and left inferior temporal (p=0.04, t =-3.36). 
GM intensity: No differences were found between MCI fast converter and MCInc, or 
between MCI slow converter and MCInc. 
 
1.3 Novel intensity measures 
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GWMR skewness: No significant group differences were found between MCIc_fast and 
MCInc. Between MCI slow converters and MCInc, GWMR was significantly less 
skewed among slow converters (FDR-corrected p=0.03, t=-3.45).   
WM skewness: Between MCI fast converters and MCInc, significant differences were 
found in 14 of 62 ROIs (FDR corrected p<0.05). In specific, MCI fast converters showed 
less skewed WM intensity in the left entorhinal cortex, bilateral fusiform, bilateral 
inferior temporal, bilateral middle temporal, left parahippocampal gyrus, left rostral 
middle frontal, and right rostral anterior cingulate. WM intensity was more skewed in left 
postcentral gyrus, right cuneus, right pericalcarine, and right transverse temporal. 
Between MCI slow converters and MCInc, significant differences were found in 1 of 62 
ROIs (FDR corrected p<0.05). In specific, MCI slow converters showed less skewed 
WM intensity in the left inferior temporal gyrus (p=0.03, t=-3.46). 
GM skewness:  Between MCI fast converters and MCInc, significant differences were 
found in 20 of 62 ROIs (FDR corrected p<0.05). For all 20 regions, GM intensity was 
more skewed in MCI fast converters compared to MCI non-converters. The most 
significant regions (p<0.01) include the left entorhinal, left fusiform, bilateral inferior 
parietal, and left precuneus. No significant difference was found between MCI slow 
converters and non-converters.  
GWMR network: Between MCI fast converters and MCInc, significant differences were 
found in 40 of 62 ROIs (FDR corrected p<0.05), with MCI fast converters having lower 
value in all 40 regions. There was no significant difference in network connectivity 




2. Machine learning classifiers 
2.1 CCF classifier 
We considered the classification performance on three different combinations of input 
features. The three input combinations are: 1) T1-weighted MRI features; 2) T1w MRI 
and neuropsychological features; 3) Neuropsychological features. Based on results from 
group comparisons, distinct feature sets are selected for classifying MCIc_fast vs. 
MCInc, and MCIc_slow vs. MCInc. The features that are selected for each classification 
were reported in Figure 3. 
 
Figure 3 Summary of features selected in CCF classifiers. The features that are used in 
the best performing classifier is highlighted, where rows represent each 
imaging/neuropsychological measure and columns are ROIs. The numbers on the x-axis 
represent ROI which can be found in the ROI list. The symbols within each box represent 
if the significant feature is bilateral or unilateral: “*” bilateral, “L” left hemisphere, “R” 
right hemisphere. MTL: medial temporal lobe. Features that are also statistically 
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significant FDR<0.05 from t-test are highlighted with red border. Neuropsychological 
tests with subscores are indicated by the labels on the squares. 
 
 
Table 5. Summary of MCI converters vs MCInc classification performances. This table 
compares the performances of classifiers using different input features. ACC: accuracy. 
SEN: sensitivity. SPE: specificity. 
Input Measures MCIc_fast vs MCInc MCIc_slow vs. MCInc 
ACC SEN SPE ACC SEN SPE 
T1 MRI features only 83.2% 83.1% 84.0% 74.4% 66.7% 78.3% 
T1 MRI + neuropsychological features 86.1% 85.5% 89.8% 80.5% 75.7% 82.3% 
Neuropsychological features only 74.4% 75.6% 66.0% 69.4% 67.0% 70.5% 
 
MCIc_fast vs. MCInc: The best performing classifier was achieved by using the 
combination of imaging and neuropsychological features. The average accuracy for the 
input combination comprising 46 T1w MRI and 12 neuropsychological features is 86.1%, 
and with a sensitivity of 85.5% and a specificity of 89.8%. Using only 46 T1w MRI 
features, the classifier achieved an accuracy of 83.2%, sensitivity of 83.1% and 
specificity of 84.0%. Using only 12 neuropsychological features, the classifier achieved 
an accuracy of 74.4%, sensitivity of 75.6% and specificity of 66.0% (Table 4). 
MCIc_slow vs. MCInc: The best performing classifier was achieved by using the 
combination of imaging and neuropsychological features. The average accuracy for the 
input combination comprising 35 structural MRI and 8 neuropsychological features is 
80.5 %, and with a sensitivity of 75.7% and a specificity of 82.3%. Using only 35 T1 
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MRI features, the classifier achieved an accuracy of 74.4%, sensitivity of 66.7% and 
specificity of 82.3%. Using only 8 neuropsychological features, the classifier achieved an 
accuracy of 69.4%, sensitivity of 67.0% and specificity of 70.5% (Table 4). 
 
2.2 Alternative classification approaches 
As described earlier, we applied alternative methods (unsupervised and 
supervised) for classifying MCIc_fast vs. MCInc and MCIc_slow vs. MCInc. Here we 
report the best performing models and the features selected by each model (Figure. 4 & 
5) 
 
Figure 4 Summary of features selected in cluster analysis classifiers. The features that are 
used in the best performing classifier is highlighted, where rows represent each 
imaging/neuropsychological measure and columns are ROIs. The numbers on the x-axis 
represent ROI which can be found in the ROI list. Light blue represents feature that were 
used in 1 of the 5 best models, while dark blue represents features that are used more than 
once. The dark red squares represent features used by all 5 models. The symbols within 
each box represent if the significant feature is bilateral or unilateral: “*” bilateral, “L” left 
hemisphere, “R” right hemisphere. MTL: medial temporal lobe. Features that are also 
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statistically significant FDR<0.05 from t-test are highlighted with red border. 
Neuropsychological tests with subscores are indicated by the labels on the squares. 
 
Cluster analysis classifier 
MCIc_fast vs. MCInc: The best performing achieved an accuracy of 88.6 %, and with a 
sensitivity of 91.4% and a specificity of 80.4%. The features used by this best-performing 
model were left pars triangularis thickness, right caudal middle frontal WM skewness, 
volumes of hippocampal subfields (right CA1-head, right whole hippocampal body, right 
CA3-body, right CA4-head, bilateral subiculum head), and neuropsychological features 
(MMSE, RAVLT_immediate, RAVLT_forgetting, ADAS13, DIGITSCOR, FAQ). A few 
other classifiers that included different feature sets also achieved a high level of 
performance. Among these, the average performance of the top 5 models achieved an 
accuracy of 86.7%, sensitivity of 90.2%, and specificity of 78.0%. The features that were 
selected by these models also consisted of both imaging and non-imaging features.  
MCIc_slow vs. MCInc: The best performing models achieved an accuracy of 81.7%, and 
with a sensitivity of 69.8% and a specificity of 92.0%. A similar model also achieved an 
accuracy of 81.7%, and with a sensitivity of 67.4% and a specificity of 94.0%. Some of 
the features used by best-performing models were left precentral thickness , left inferior 
parietal volumes and GWMR skewness, volumes of hippocampal subfields (left whole 
hippocampal body, left CA3-body, right subiculum body, etc.), and some 
neuropsychological features (MMSE, RAVLT_learning, CDRSB, ADASQ4, 
DIGITSCOR, FAQ). A few other classifiers that included different feature sets also 
achieved a high level of performance. Among these, the average performance of the top 5 
 
29 
models achieved an accuracy of 80.9%, sensitivity of 71.6%, and specificity of 88.8%. 
The features that were selected by these models also consisted of both imaging and non-
imaging features.  
 
Other supervised classifiers: 
MCIc_fast vs. MCInc: The best performing supervised classifier achieved an accuracy of 
86.2 %, and with a sensitivity of 93.5% and a specificity of 64.9%. The classifiers applied 
a random forest algorithm and included 5 imaging features and 4 cognitive features.  
MCIc_slow vs. MCInc: The best performing supervised classifier achieved an accuracy of 
77.4 %, and with a sensitivity of =69.0% and a specificity of 90.0%. The classifiers 
applied a support vector machine algorithm and included 10 hippocampal subfield 
volume features and 7 neuropsychological features. Another classifier demonstrated a 
similar level of performance with an accuracy of 76.4 %, and with a sensitivity of 63.5% 
and a specificity of 84.0%, using a support vector machine algorithm and only 3 imaging 









 For the early identification of MCI subjects with a high risk of conversion to AD, 
we 1) conducted group-level statistical comparisons on standard T1-weighted structural 
MRI measures (i.e. thickness, area, volume, signal intensities), novel signal intensity-
based skewness and network measures, and neuropsychological measures, and 2) applied 
machine learning algorithms that combines significant features defined through statistical 
analyses to classify subgroups within the MCI cohort. Compared to MCI subjects who 
did not convert for at least 5 years (MCInc), we found that MCI subjects who converted 
to AD within 0-2 years (MCI fast converters) demonstrated significant changes to brain 
morphometry and intensity profiles across all 4 lobes (Figure 2). MCI subjects who 
converted to AD within 3-5 years (MCI slow converters) demonstrated selective changes 
mainly in the temporal regions and the hippocampus. After identifying features 
associated with each group, we developed computational models that allowed us to 
classify MCI fast converter and MCInc with an accuracy of 86.1%, and classify MCI 
slow converters from MCInc with an accuracy of 80.5%. Overall, these results suggest 
that neuroimaging markers are important for defining subgroups of MCI subjects who 
remain stable or convert to AD at different rates.  
MCI subgroups characteristics 
Many previous studies of MCI have focused on the conventional subtypes of MCI 
to identify those at highest risk for AD. However, this classification system was 
established primarily based on neuropsychological characteristics and grouped all 
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individuals with non-memory deficits (e.g., language, visuospatial, attention, executive 
function) as “amnestic” or “non-amnestic”, which may not adequately capture the 
heterogeneity of MCI for accurate disease prognosis. Therefore, we defined subgroups of 
MCI based on the MCI-AD conversion status and conducted group comparisons on 
various MRI and neuropsychological measures. For ROI-level morphometric measures, 
we found that MCI fast converters (0-2 years) had bilateral decrease of cortical thickness 
and volume compared to the MCI non-converters across all 4 lobes. In contrast, MCI 
slow converters (3-5 years) had more focal atrophies at right entorhinal, left 
supramarginal gyrus, bilateral amygdala and hippocampus compared to MCInc. This is 
consistent with a previous longitudinal study showing that at 3 years before the diagnosis 
of AD, GM loss in MCI focused primarily on the medial temporal lobe (MTL) structures, 
then spread throughout temporal lobe, also into the temporoparietal association 
neocortex, parietal lobes, and frontal lobes at the time of conversion (Whitwell et al., 
2007). For comparisons of the intensity profile measures, GWMR was significantly lower 
in MCI fast converters in MTL regions including bilateral entorhinal and bilateral 
parahippocampal gyri. The reduction of GWMR is likely related to changes in the WM 
intensity, not GM intensity, in the same regions as shown by our group statistics. There is 
evidence that WM pathology occurs early on during the development of MCI and may be 
related to MCI-AD conversion (van Straaten et al., 2007). Among subcortical structures, 
significant bilateral hippocampal and amygdala atrophy, and enlarged lateral ventricles 
are observed in both MCI converter groups. We also observed significant group 
differences in neuropsychological data, where MCI fast converters demonstrated greater 
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deficits on the neuropsychological tests than MCI slow converters when compared to 
MCInc. We additionally tested AD subjects as a reference group and found significant 
cortical atrophy and decreased intensity compared to the MCI subjects across all 4 lobes, 
especially in entorhinal cortex and other MTL structures (results not shown).  This 
suggests that the MCI-AD conversion is a gradual process, and at 0-2 years before 
conversion, there is already a significant amount of neurological damage accumulated. 
Therefore, we think that predicting the risk of conversion at a much earlier time point 
would be more clinically significant. 
MCI subgroups and the hippocampus 
From our group comparison results, we showed that both MCI fast converters and 
slow converters demonstrated bilateral hippocampal atrophy compared to the non-
converters. However, when we additionally segmented the hippocampus into subfields, 
we saw some different atrophy patterns in fast and slow converters. For MCI fast 
converters, almost all subfields showed bilateral loss of volume. The MCI slow 
converters also demonstrated significant atrophy in 17 of 22 subfields, but with a few 
being restricted only to the left hippocampus. This progressive spread of atrophy from 
focal subregions to the rest of the hippocampus was also evident during the conversion 
from MCI to AD (Flores et al., 2015). More recent paper suggested that changes to 
specific subfields in healthy elderlies were significantly associated with performances on 
various cognitive tests (Zammit et al., 2017). These evidence support the idea that some 
hippocampal subfields may be more vulnerable to disruptions than others during the early 
stage of MCI. We think that measuring subtle changes in specific hippocampal subfields 
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may occur long before the atrophy of the whole hippocampus or atrophy of cortical 
regions, and can be used as better biomarkers for detecting the early stages of 
neurological disorders than using the whole hippocampus. This is also evident in our 
group analyses, for example, for the MCI slow converters, hippocampal subfield volume 
measures resulted in more numbers of features than cortical ROI measures, which may be 
important for differentiating between MCI slow converters and non-converters.  
MCI subgroups and novel intensity markers  
From our group comparison results, we noticed that while the MCI fast converters 
can be well characterized by the standard T1-weighted morphometric measures and 
intensity measures, we were only able to identify 4 features for the slow converters using 
those measures (Figure 2). As mentioned earlier, a recent paper showed that the rate of 
MCI-AD conversion (measured by greater cognitive decline over a fixed time interval) 
was associated with both WMH and T1-weighted hypointensity (Dadar et al., 2019). 
Based on this finding, for better characterization of the MCI slow converters, we 
developed novel imaging markers, intensity skewness and network measures, based on 
the standard ROI-level GM/WM intensity and GWMR measures. The skewness measure 
was generated by sampling all vertices within each ROI in order to describe the shape of 
the distribution. In other words, while standard ROI measures provide an average 
intensity value for each ROI, the skewness measure takes into account some of the more 
extreme values. Along the same line, the GWMR network measure was generated using 
the mean and standard deviation of ROI measures to estimate the relationship between a 
pair of ROIs. This measure can be useful even when there are no changes to intensity 
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profile on the single ROI level, but changes to the connectivity/covariance between ROIs 
that may suggest disrupted neural networks. We think that these novel intensity measures 
may be especially useful for detecting subtle changes in the intensity profile as it provides 
information that is overlooked by the standard ROI measures. As evident in our group 
comparison results, the GM and WM skewness measures demonstrated more extensive 
differences between MCI fast converters and non-converters compared to standard GM 
and WM intensity measures. The regions highlighted by the conventional and novel 
intensity measures also seem to overlap in many cases, suggesting consistency between 
these features. For MCI slow converters, we were able to identify 2 additional features 
using our novel intensity measure.  
Alternative approach for defining MCI subgroups 
 While our group comparison results provided group-specific patterns by applying 
a statistical threshold for identifying important features, we wondered if these significant 
features alone were sufficient for distinguishing MCI subgroups, and if there were other 
hidden features overlooked by the conventional analytical methods. We found that by 
using statistically significant baseline T1-weighted MRI features and neuropsychological 
features selected based on group comparisons, we were able to classify MCI fast 
converters (0-2 years) from non-converters with an average accuracy of 86.1%, 
sensitivity of 85.5%, and specificity of 89.8%. This result is slightly better than a 
previous classification model for MCI converters (0-3 years) and MCI non-converters 
with 84.1% accuracy using the combination of T1 MRI and cognitive markers (Tong et 
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al., 2017). Our model performance is similar to a recent deep learning study that achieved 
86% accuracy, 87.5% sensitivity, 85% specificity for classifying MCI converters (0-3 
years) and non-converters, by using both baseline T1-weighted MRI features and clinical 
data (Spasov et al., 2019). On the other hand, for classifying MCI slow converters, only 
using the few statistically significant features highlighted in Figure 2 did not provide the 
best classification performance. When we added a few other features that were at 
marginal significance (significant under uncorrected p-value), we were able to generate a 
best performing model at an accuracy of 80.5%, sensitivity of 75.7%, and specificity of 
82.3%. To our knowledge, this classification model is the first one to expand the 
prediction range to 5 years and still achieve an accuracy over 80%. In comparison, a 
recent study using T1-weighted MRI volumetric measures achieved an accuracy of 
77.0% (sensitivity = 59.6, specificity = 86.1) for classifying MCI converters (0-48months) 
and non-converters (Ezzati et al., 2019). 
Machine learning approach for classifying MCI subgroups 
From the classification results using our CCF pipeline, we found that 1) the 
combination of MRI and neuropsychological features achieved better performance than 
using one type of measure alone, 2) classifying MCIc_slow subjects from MCInc is more 
difficult than classifying MCIc_fast from MCInc, 3) the best performing classifiers 
showed both overlapping and distinct features for MCIc_fast and MCIc_slow groups. 
Our result is consistent with a previous study that showed combining clinical data and 
imaging markers to build the classifier improves the performance compared to just using 
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imaging markers (Moradi et al., 2015). For example, classifying MCI fast converters 
using only T1 MRI measures achieved an accuracy of 83.2%, which was higher than 
using only neuropsychological features (accuracy 74.4%), but lower than the combined 
approach with an accuracy of 86.1%. Similar pattern was also observed for the 
classification of MCI slow converters. Since the MRI-based classifier performed better 
than the neuropsychological-based classifier, but worse than the multimodal classifier, we 
reasoned that neuropsychological measures likely provided complementary information 
to imaging markers that helped to improve the prediction accuracy. The comparison of 
different methods for MCI-to-AD conversion prediction is hampered by the fact that 
nearly all works use a different classification of the subjects into stable and progressive 
MCI. To our knowledge, most classification studies define MCI converters and non-
converters based on a 0-36 months range. In our study, we expanded this range to 60 
months, and subdivided converter subjects into 2 groups. We reasoned that within 2 years 
before the conversion to AD, a substantial amount of neurological damage had already 
accumulated, as evident in our group statistics. Finally, we found that while some 
important features overlap in MCI fast and slow converters, each group also demonstrates 
unique characteristics. For example, even though both classifiers include the thickness of 
the entorhinal cortex and fusiform gyrus, MCIc_fast incorporates bilateral structures 
instead of unilateral structure as in MCIc_slow. The skewness of left pars opercularis 
GWMR is also a unique feature for MCIc_slow, and removal of this feature from the 
classifier decreased the performance. 
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By only using T1-weighted structural MRI and neuropsychological features, the 
performance of our classifier was comparable and even better than other recent studies 
that used multi-modal imaging data. For example, by combining CSF markers, structural 
MRI markers (cortical thickness and volume), FDG-PET markers, and clinical data, the 
classification using 3 different algorithms (Support vector machine, multiple kernel 
learning, and generalized linear models) achieved best average accuracy at 81% for 
classifying progressive MCI (0-3 years) vs. non-progressive MCI (Varatharajah et al., 
2019). Another study using similar features for classifying MCI converters (0-48 months) 
and non-converters showed an accuracy of 72% (Schaffer et al., 2013). Another group 
combined resting-state functional MRI (rsfMRI) and structural MRI features and 
achieved an accuracy of 97.0% for classifying MCI converters (0-3 years) and MCI non-
converters (Hojjati et al., 2018). It is worth noting that studies using rsfMRI and PET 
data usually suffer from small sample sizes, as these techniques are not as easily 
accessible as the conventional T1-weighted MRI.  
Alternatively, we applied a cluster analysis approach for the classification of MCI 
subgroups. In contrast to the CCF method that conducts subject-level classification, the 
clustering method is more specific to a certain data set, as it creates data-driven labels 
based on the input sample. This method also implemented a random feature selection 
which could potentially highlight additional features that were not significant based on 
group comparison results. In terms of the classification performance, we achieved a 
similar average accuracy as CCF for the MCIc_fast classifier at an accuracy of 86.7%, 
sensitivity of 90.2%, and specificity of 78.0%, and for the MCIc_slow classifier at an 
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accuracy of 80.9%, sensitivity of 71.6%, and specificity of 88.8%. Interestingly, while 
CCF and cluster analysis showed overlapping features such as the thickness of fusiform 
gyrus, cluster analysis provided additional features in the frontal and parietal regions, 
such as the cingulate cortex.  
Limitations and future directions 
Our study had several limitations that should be considered in further 
investigations. First, as discussed in previous papers, the cut-off period (0-2 years, and 3-
5 years) used here is arbitrary and was determined based on the frequency and length of 
follow-up for the original ADNI-1 project (Adaszewski et al., 2013). This makes the 
exact time of conversion less accurate. Secondly, the sample size of each group is 
unbalanced, especially that the fast converters have much more subjects compared to the 
other three groups. This can lead to the model consistently labeling subjects as fast 
converters in order to achieve a higher accuracy. We expect that in the clustering 
approach, the lower specificity relative to sensitivity for MCIc_fast classifier, and lower 
sensitivity relative to specificity for MCIc_slow classifier could be due to issues related 
to unbalanced sample sizes. The small sample size and large feature pool is especially 
challenging for building ML classifiers, as it can result in large variances and model 
overfitting. Thirdly, as our study only used baseline data, we could not infer that the rate 
of conversion is different between the MCI slow and fast converters, rather, we can only 
suggest that these are MCI subjects who converted to AD at different time points during 
the follow-up. As for the next step, we plan to incorporate second time point data which 
will allow us to generate additional features on a longitudinal timeline. Lastly, most of 
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our intensity measures focussed on peripheral brain structures. As previous studies 
suggested, WM pathology related to MCI-AD conversion mostly occurs in the 
periventricular regions (Dadar et al., 2019). For the next step, we plan to extract intensity 
profiles near the ventricular regions to identify additional group-specific features.  
In conclusion, we demonstrated that T1-weighted structural MRI markers can be 
used to differentiate MCI subjects who converted to AD from those who remained 
clinically stable. We also developed classifiers to predict the conversion from MCI to AD 
by combining MRI and neuropsychological markers using our in-house CCF algorithm. 
Our best performing classifier achieved a very high predictive performance, with an 
accuracy of 86.1% for classifying MCI fast converters from MCI non-converters, and an 
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